Spectrum of morphologic alterations of regression in cutaneous melanoma--potential for improving disease prognosis

Sabina Zurac1, Gabriela Negroiu, Stefana Petrescu

  • 1"Colentina" University Hospital, Dept. of Pathology, Bucharest, Romania. sabina_zurac@yahoo.com

Abstract

Insights

Melanoma regression, a complex interplay of tumor cells and immunity, shows varied prognostic significance. Segmentary regression (SR) in thin melanomas appears more favorable than partial regression (PR).

Area of Science:

  • Dermatopathology
  • Oncology
  • Immunology

Background:

  • Melanoma regression involves intricate interactions between tumor cells and the host immune response.
  • The precise biological mechanisms and prognostic implications of melanoma regression remain incompletely understood.
  • Understanding regression is crucial for developing effective anti-cancer vaccine strategies.

Purpose of the Study:

  • To analyze histopathological features of melanoma regression.
  • To compare different types of regression: segmentary (SR), partial (PR), and segmentary & partial (SR-PR), versus no regression (AR).
  • To investigate the prognostic significance of regression subtypes in melanoma.

Main Methods:

  • Analysis of 127 superficial spreading melanomas.
  • Classification of melanomas into SR, PR, SR-PR, or AR groups.
  • Registration of histopathological parameters and statistical analysis (P < 0.05).

Main Results:

  • Regression was observed in 52% of cases, less frequently in pT4 melanomas.
  • SR and SR-PR melanomas exhibited significantly higher tumor-infiltrating lymphocytes compared to AR melanomas.
  • SR melanomas showed fewer mitoses and higher vascular hyperplasia than other regression types and AR.

Conclusions:

  • Different regression patterns may represent distinct processes involving inflammation and tumor destruction.
  • Segmentary regression (SR) appears to have a more favorable prognosis, particularly in thin melanomas.
  • Further research is needed to fully elucidate the mechanisms underlying melanoma regression.

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...